Appoints a new director of Regulatory Affairs and a new director of Business Development
Pharmalink, a Swedish specialist pharma company, has appointed Heather Cook as director of Regulatory Affairs and Marek Poszepczynski as director of Business Development.
Cook brings to Pharmalink more than 15 years of experience within the pharmaceutical industry, with a track record in global regulatory affairs and clinical development. Prior to joining Pharmalink, she was head of department for Regulatory Development Projects at Lundbeck. She was also Global Regulatory Affairs director, Oncology for AstraZeneca and held a number of other senior roles including scientific director for Neuroscience and Infection. She has worked in the UK, Canada, and Denmark and currently lives in Stockholm.
Poszepczynski joins Pharmalink after a career spanning 10 years and combining financial and business development experience. Hes was previously lead equity analyst at Handelsbanken covering European and Swedish biotechnology stocks. Prior to this he was vice president of Business Development at Karolinska Development.
Poszepczynski also spent six years at BioVitrum where he was director of Corporate Development.